SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-045196
Filing Date
2024-05-20
Accepted
2024-05-20 16:16:31
Documents
7
Effectiveness Date
2024-05-20

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0206518-s8_ysbio.htm S-8 54400
2 OPINION OF MAPLES AND CALDER (HONG KONG) LLP, REGARDING THE VALIDITY OF THE ORDI ea020651801ex5-1_ysbio.htm EX-5.1 11721
3 CONSENT OF WEI, WEI & CO., LLP ea020651801ex23-1_ysbio.htm EX-23.1 2235
4 FILING FEE TABLE ea020651801ex-fee_ysbio.htm EX-FILING FEES 25613
5 GRAPHIC ex5-1_001.jpg GRAPHIC 2700
6 GRAPHIC ex23-1_001.jpg GRAPHIC 8528
7 GRAPHIC ex23-1_002.jpg GRAPHIC 12892
  Complete submission text file 0001213900-24-045196.txt   128861
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
YS Biopharma Co., Ltd. (Filer) CIK: 0001946399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-279544 | Film No.: 24964695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)